Nuclear inositides
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: 17 December 2009
Authors
DAG, 1,2-diacylglycerol; EGF, epidermal growth factor; TNF, tumour necrosis factor; IGF-I, insulinlike growth factor I; Ins(n)P, inositol phosphate; Ins(n,n)P2, inositol bisphosphate; Ins(n,n,n)P3, inositol trisphosphate; MEL, murine erythroleukemia (Friend); PIC, phosphoinositidase C (phosphatidylinositol- specific phospholipase C); PKC, protein kinase C; PKB, protein kinase B; PLC, phospholipase C; PLD, phospholipase D; PMA, phorbol 12- myristate 13-acetate; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; PtdIns, phosphatidylinositol; PtdIns(x)P, phosphatidylinositol monophosphate, phosphorylated at position x; PtdIns(x,y)P2, phosphatidylinositol bisphosphate, phosphorylated at position x and y; PtdIns(n,n,n)P3, phosphatidylinositol trisphosphate; PtdOH, phosphatidic acid.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
